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Review
Over the past 20 years, acknowledgment of the 
unique vulnerabilities of children to the disrup-
tion of normal growth and development caused 
by environmental exposures has grown. The 
health impacts of many chemicals have been 
shown to differ based on the developmental 
window of susceptibility (e.g., periods of rapid 
cell proliferation or differentiation) when expo-
sure occurs. Although the neurologic system 
has been most widely studied in this regard, 
there is a growing body of knowledge about 
the potential impacts of environmental expo-
sures on lung growth and function. Respiratory 
disease has a large public health impact. An 
estimated 24 million U.S. adults have chronic 
obstructive pulmonary disease; 23 million have 
asthma; and chronic lower respiratory diseases 
rank as the fourth leading cause of death in 
the United States (Kung et al. 2008; National 
Heart, Lung, and Blood Institute 2007). In this 
article, we first present an overview of essential 
processes in lung development, followed by 
examples of xeno  biotics, including important 
environmental contaminants, that can disrupt 
these processes.
Epidemiologic confirmation of the impor-
tance of the impact of early-life exposures, as 
originally described by Barker (the Barker 
hypothesis; Barker and Osmond 1986), has 
developed into a burgeoning field of study: 
the fetal origins of adult disease. Barker’s work 
demonstrating that poorer fetal nutrition 
and lower birth weight are associated with 
cardio  vascular disease in adults has since been 
confirmed in multiple longitudinal studies 
around the world (Barker 2007). This finding 
was based on the observation that populations 
living in regions with poor fetal nutrition had 
higher risk of adult cardio  vascular disease. 
Yet, paradoxically, geographical areas most 
associated with fetal or neo  natal mortality 
and low birth weight (e.g., from poor nutri-
tion) were not those at greatest risk for known 
post  natal risk factors for cardio  vascular disease 
(e.g., high income, increased fat in diet). The 
premise for the early origins of adult disease 
is that during early life, “programming” in 
response to poor fetal nutrition results in per-
manent changes in organ structure, metabo-
lism, and function. For example, lower birth 
weight has been associated with increased 
likelihood of having adult lipid profiles linked 
to cardio  vascular risk as well as hypertension 
and impaired glucose regulation (Gluckman 
et al. 2008; Kajantie et al. 2008). 
Although Barker’s original ecologic epide-
miologic findings also showed a link between 
low birth weight and adult respiratory health, 
this was not accorded the same importance 
because geographic areas that had higher 
incidence of low birth weight and neonatal 
mortality were also regions with more post-
natal risk factors (e.g., infection) for adult 
respiratory diseases. However, more recent 
studies provide evidence that in utero and 
early post  natal exposures set the stage for 
both childhood and later-life deficiencies in 
lung function that are predisposing factors 
for chronic obstructive lung disease and other 
disorders (Bush 2008; Canoy et al. 2007; 
Shi et al. 2007). For example, Stern et al. 
(2007) found that maximal expiratory flow 
at functional residual capacity meas  ured in 
123 infants at 2 months of age was associated 
with lung function measurements, includ-
ing forced expiratory volume in 1 second 
(FEV1)/forced vital capacity (FVC), forced 
expiratory flow between 25% and 75% of 
FVC (FEF25–75), and FEV1, up to 22 years 
of age (Figure 1). In a longitudinal study of 
243 infants, 4-week-olds with flow-limited 
tidal expansion (inability to increase expira-
tory flow with increased effort) were 7 times 
more likely to be diagnosed with asthma at 
2 years of age (Young et al. 1994). These 
investigators observed a statistically significant 
increase in wheezing and a trend to reduced 
FEF25–75 at 11 years of age compared with 
children who had normal tidal expansion as 
infants (Turner et al. 2002). Similarly, airway 
responsiveness to histamine at 1 month of age 
was associated with abnormal airway function 
(decreased FEV1 and FVC), lower respira-
tory symptoms, and emergence of asthma 
by 6 years of age in a study of 95 children 
(Palmer et al. 2001). Several sizable studies 
from various countries have demon  strated 
that lung function in both asthmatics and 
non  asthmatics tracks from early childhood 
through adolescence and up to mid  life, and 
is set by early-life events (Haland et al. 2006; 
Morgan et al. 2005; Oswald et al. 1997; 
Phelan et al. 2002; Stern et al. 2007). These 
studies support the importance of early-life 
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programming of respiratory system structure 
and function and its life-long implications.
The Endogenous Fetal 
Environment: Impacts on Fetal 
Respiratory Development
Evidence for the potential impact of the early- 
life environment on adult respiratory sta-
tus stems from examination of the effects of 
fetal nutrition and sex. Intrauterine growth 
retardation (IUGR), often defined as low birth 
weight (< 10th percentile) for gestational age, 
has been identified as a risk factor for impaired 
lung function in children (Ergaz et al. 2005; 
Kotecha et al. 2010; Nikolajev et al. 2008). 
The reduction in nutrients and oxygenation 
related to IUGR may interfere with structural 
development of the lung (Lipsett et al. 2006). 
In an animal model, IUGR induced in late 
gestation produced alterations in alveolar func-
tion, corresponding to rapid development of 
alveoli during this time period (Maritz et al. 
2001). Alterations include a thickened alveolar 
blood–gas barrier that persists into adulthood. 
In epidemiologic studies, birth weight has been 
demonstrated to be related to reduced lung 
function in adults (Canoy et al. 2007; Lawlor 
et al. 2005; Stein et al. 1997), and IUGR has 
been associated with poorer lung function at 
8–9 years of age even when accounting for 
catch-up growth (Kotecha et al. 2010).
Endogenous chemicals, including estro-
gens and androgens, are associated with 
modu  lation of lung development and func-
tion (Carey et al. 2007). Both estrogen and 
androgen receptors are expressed in the human 
lung during fetal development and play a role 
in sexually dimorphic differentiation. For 
example, in humans, surfactant production 
and maturation appear earlier in females and 
may be a reason that males are more prone 
to respiratory distress syndrome (caused by 
surfactant deficiency) (Fleisher et al. 1985; 
Perelman et al. 1986). Androgens inhibit sur-
factant production via alterations in epider-
mal growth factor and transforming growth 
factor-β signaling (Dammann et al. 2000). In 
contrast, estrogen adminis  tration can stimulate 
surfactant production and lung maturation in 
the fetal rat and rabbit (Khosla et al. 1981). 
For premature infants, human male singletons 
or twins are at greater risk for respiratory mor-
bidity and respiratory distress syndrome than 
are female singletons or twins. Shinwell et al. 
(2007) conducted a population-based study 
of 8,858 very-low-birth-weight pre  mature 
infants to examine mixed-sex premature twins. 
Female infant respiratory morbidity was com-
parable with that of males, suggesting that a 
male disadvantage was transferred via an intra-
uterine paracrine mechanism to the female 
(Shinwell et al. 2007). Melamed et al. (2009) 
analyzed 2,704 twin births and found a similar 
disadvantage to the female in mixed-sex twins. 
Large-airway growth lags behind parenchymal 
growth in human males (relative to females), 
resulting in relatively narrower conducting 
airways (Becklake and Kauffmann 1999; 
Hoffstein 1986).
These examples show that the nutritional 
and endogenous chemical environments affect 
development of the lung and that these effects 
can be permanent, altering function in the 
adult. In this review we examine the basis 
for concern that similar adverse effects on 
lung development may occur after exposure 
to xeno  biotics during critical windows in early 
life. We also discuss implications for regula-
tion of environmental chemicals. 
Overview of Lung 
Development
The biology of lung development has been 
reviewed in many books and papers (e.g., 
Harding et al. 2004; Pinkerton and Joad 
2000) and is briefly summarized here.
Stages of lung development. In humans, 
primary lung buds develop during the fourth 
week of gestation from the endoderm of 
the foregut. After early embryonic develop-
ment, stages in prenatal lung development are 
pseudo  glandular, canalicular, saccular, and 
alveolar, which are represented in Figure 2, 
along with associated develop  mental features 
(Kajekar 2007). Only a portion of maturational 
events are required prenatally for successful sur-
vival, with most continuing postnatally during 
alveolarization (Pinkerton and Joad 2000).
The embryonic period is characterized 
by initial outpouching of primary bronchi 
from the primitive gut, which elongate into 
the mesenchyme and divide into two main 
bronchi. During the pseudo  glandular phase 
(6–16 weeks of gestation in humans), branch-
ing continues and mesenchyme differentiates 
into cartilage, smooth muscle, and connective 
tissue around the epithelial tubules. By the 
end of this time, major conducting airways 
to the terminal bronchioles are developed. 
Respiratory bronchioles, which end in thin-
walled dilatations (terminal sacs or primitive 
alveoli), develop in the canalicular period along 
with a rich vascular supply. During the saccular 
phase, first contact between the air space and 
proliferating pulmonary capillaries takes place. 
Epithelial cells differentiate into type I (thin) 
and type II (cuboidal). During alveolarization, 
the primitive alveoli develop secondary septa 
that form the walls of the true alveoli, resulting 
in a dramatic increase in surface area.
Cell types lining the conducting airway 
(trachea to midsize bronchioles) include cili-
ated cells, goblet cells (which produce mucus), 
and basal cells (stem cells for other cell types). 
The respiratory bronchioles include alveoli 
periodically along their surface. When the 
alveoli begin to dominate the surface area, 
they are termed alveolar ducts. Type I alveo-
lar epithelial cells (AECs) are predominant 
in the alveolar wall and are associated with 
gas exchange. Type II AECs, which become 
mature during the alveolar stage, are the source 
of pulmonary surfactant. Premature infants 
lack sufficient numbers of differentiated 
type II AECs, often resulting in respiratory 
distress syndrome from inadequate produc-
tion of surfactants. Alveolarization continues 
from late gestation (about 30 weeks) through 
Figure 1. Predicted mean values for lung function 
in males at 11, 16, and 22 years of age by length-
adjusted infant lung function, standardized to 
mean height and weight and measured as maxi-
mal expiratory flow at functional residual capacity 
(Vmaxfrc); 14% of variance in lung function of young 
adults was related to airway function at 2 months. 
Reprinted from The Lancet, Vol. 370 (Stern DA, 
Morgan WJ, Wright AL, Guerra S, Martinez FD. 
2007. Poor airway function in early infancy and lung 
function by 22 years: a non-selective longitudinal 
cohort study. Lancet 370:758–764), copyright (2007), 
with permission from Elsevier. Impact of environmental chemicals on lung development
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at least the first 2 post  natal years. Growth of 
the lung continues through late adolescence 
(Gauderman et al. 2004).
There are > 40 morphologically differenti-
ated cell types in the mature lung (Warburton 
et al. 1998). The development of each of these 
differentiated cell types is influenced by the 
spatial and temporal distribution of a variety 
of signaling molecules and their receptors, 
which regulate normal morphologic structure 
and function.
Branching morphogenesis. Repeatedly 
branched structures develop when there is a 
need to maximize the contact between a struc-
ture and the surrounding environment. This 
organizational strategy packs a large area of 
contact into a small space (Davies 2006) and is 
a highly conserved process for organ growth in 
many structures, including the lung, kidney, 
salivary glands, prostate, and breast. Branching 
morphogenesis is a recurring, iterative pattern-
ing event of bud growth, bud elongation, and 
subdivision of terminal units (Cardoso 2004). 
In the lung, branching is used to generate the 
bronchial tree, including secretory glands, 
blood vessels, and interalveolar septa.
Mesenchyme develops from the mesoderm 
and gives rise to the lung’s connective tissue, 
endothelial cell precursors, smooth muscle 
that surrounds the airways and blood vessels, 
the lymphatic system, and the pleura. The 
lung develops in proximal-to-distal fashion 
but also in a specified right/left asymmetrical 
manner. These events develop in a cascade, 
each building on earlier activity and reiter-
ated over several generations of branching 
to form the respiratory tree. Although many 
details of the regulation of these events are still 
unknown, numerous animal studies have illu-
minated many of the signaling pathways and 
transcription factors that direct lung develop-
ment. Physical factors such as stretch and fluid 
volume also influence lung development.
Perhaps more important from a toxico-
logic perspective, reciprocal exchange of 
signaling factors between epithelial and mes-
enchymal cells is essential to normal develop-
ment (reviewed by Cardoso and Lu 2006). For 
example, members of the fibroblast growth 
factor (FGF) family, soluble factors produced 
in the mesenchymal cells that signal tyrosine 
kinase receptors (Fgfr1–4) in the epithelial 
cells, are essential for bud initiation. Studies 
in organ culture show that the epithelium will 
migrate and proliferate toward Fgf10 (Park 
et al. 1998). Correct development of lung 
branching requires temporal and spatial con-
trol over Fgf10 levels (Bellusci et al. 1997; 
Mariani 2007). In rodents, deletion of Fgf10 
or lack of retinoic acid (RA), a crucial cofactor 
for FGFs, results in lung agenesis (Cardoso 
and Lu 2006; Desai et al. 2004; Sekine et al. 
1999). Inhibitory control over Fgf10 involves 
sprouty (Spry2) and sonic hedgehog (Shh), 
which are highly diffusible factors secreted by 
the epithelium of the developing lung bud 
(Mason et al. 2006; Warburton et al. 2005). 
The Fgf10 in the distal mesenchyme diffuses 
into the epithelial bud and binds to the recep-
tor, Fgfr2b, to induce budding and initiate 
branching (Bellusci et al. 1997). Fgfr2 activity 
induces Spry2, which inhibits FGF signal-
ing and inhibits bud growth (Mailleux et al. 
2001). Shh is highly expressed in the bud’s 
distal epithelium (Cardoso 2004). Shh from 
the bud is believed to progressively down-
  regulate FGF activity as the bud grows toward 
the Fgf10-expressing mesenchyme (Lebeche 
et al. 1999). In mice, over  expression of Spry2 
or inhibition of Shh results in impairment of 
branching (Bellusci et al. 1997; Cardoso 2004; 
Lebeche et al. 1999; Mailleux et al. 2001).
Vascular endothelial growth factors 
(VEGF), necessary for development of 
the lung vasculature, are expressed in both 
branching tubular airways and vascular mesen-
chymal cells. The coordinated development of 
the epithelial and endothelial compartments 
depends on a VEGF gradient being present 
from its production at the tips of growing 
airway tubules (Voelkel et al. 2006). In a 
number of murine models, over  expression 
of VEGF results in dysmorphogenesis, and 
under  expression of VEGF or neutralization 
of VEGF results in poor septal formation and 
emphysematous changes (Gerber et al. 1999; 
Voelkel et al. 2006). These are only examples 
of the many signaling pathways that must be 
expressed in a precise temporal and spatial 
pattern for normal lung growth and develop-
ment (Maeda et al. 2007).
The trachea develops from an out  pouching 
of the foregut and requires formation of 
a separa  tion between the two tissues. Mice 
deficient in Shh or RA or that lack Nkx2.1, 
the gene for a transcription factor active in 
early lung development [also called thy-
roid transcription factor 1 (Ttf1)], develop 
an incomplete separation of the foregut and 
trachea known as a tracheo  esophageal fistula 
(Litingtung et al. 1998; Minoo et al. 1999). 
This is a relatively common congenital anom-
aly in humans and has been associated with 
down-regulation of the FGF pathways and 
aberrant Shh signaling (Crisera et al. 2000; 
Spilde et al. 2003).
Alveolarization. As reviewed by McGowan 
and Snyder (2004), during the saccular phase 
the terminal portions of the airways give rise 
to alveolar ducts and sacs with thick walls of 
connective tissue and limited ability for gas 
exchange. The primary septa (the walls of the 
terminal sacs) have a central core of fibroblasts 
and connective tissue surrounded on each 
side by capillaries and epithelial cells. During 
alveolarization, ridges develop in the primary 
septa and become the secondary septa.
In humans, a period of rapid alveolar 
development lasts from about 36 weeks of 
gestation to about 2 years of age. From sev-
eral months until 3 years of age, a second 
phase of alveolarization occurs, characterized 
by micro  vascular remodeling, thinning and 
lengthening of the secondary septae, loss of 
mesen  chymal cells, and change from a dual 
to a single capillary bed. From birth until 
maturity, there is a 20-fold increase in gas-
exchange surface area (Burri 2006). Recent 
Figure 2. Principal stages of lung development in humans: diagrammatic representations of the timeline 
and developmental organization of trachea, primary bronchi, intrapulmonary bronchi, and acinus in the 
mammalian respiratory system. Reprinted from Pharmacology and Therapeutics, Vol 114 (Kajekar R. 2007. 
Environmental factors and developmental outcomes in the lung. Pharmacol Therap 114:129–145), copyright 
(2007), with permission from Elsevier. Miller and Marty
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evidence in non  human primates suggests that 
alveoli increase in number through young 
adult  hood (Hyde et al. 2007). If confirmed, it 
would expand the sensitive time period dur-
ing which disruption of molecular mecha-
nisms of alveolar development is of special 
concern, from the first few years of life until 
termination of longitudinal growth.
Cellular differentiation and repair. With 
> 40 distinct cell phenotypes represented in 
the mature lung, undisturbed cellular differ-
entiation is important to future lung func-
tion. In general, differentiation occurs in a 
proximal to distal sequence, with the tracheal 
epithelial cells differentiating first. Thus, iden-
tical critical processes involving cell signal-
ing in development are occurring at different 
times, depending on the location proximal to 
distal in the respiratory tree.
Cross-talk between endothelial cells and 
epithelial cells is essential for differentiation 
of these cell types. VEGF-A expressed by the 
lung epithelium is essential to pulmonary cap-
illary development. In mice, deficient capil-
lary development by selective inactivation of 
the Vegf-A gene in the respiratory epithelium 
results in disruption of primary septae for-
mation during alveolarization (Gerber et al. 
1999; Yamamoto et al. 2007). Yamamoto 
et al. (2007) also demon  strated that hepato-
cyte growth factor (Hgf) expression in the 
developing endothelium is essential for nor-
mal epithelial development.
The transcription regulatory protein GATA 
binding protein 6 (GATA-6), expressed in lung 
epithelial cells, interacts with TTF1. In mouse 
models, inhibition of GATA-6 during fetal 
life inhibited terminal differentiation of respi-
ratory epithelial cells (Liu et al. 2002; Yang 
et al. 2002). Elevated levels of GATA-6 post-
natally (when levels normally are decreased) 
resulted in alterations in alveolar septation 
causing increased lung volumes and air space 
enlargement that persisted into adulthood (Liu 
et al. 2003). Airway resistance and airway and 
tissue elastance were significantly decreased. 
This provides an example of morpho  genesis 
dependent on the precise timing of expres-
sion of GATA-6. Few studies have examined 
the impact of environ  mental chemicals on 
GATA-6 expression. 
Clara cells are nonciliated bronchiolar 
cells and are the principal epithelial cells in 
the distal airway, whose products include 
Clara cell secretory protein and some compo-
nents of surfactant. Clara cells are important 
in the metabolism of airborne toxicants due 
to their high cytochrome P450 (CYP450) 
content and are particularly sensitive to injury 
by xeno  biotics, in part as a result of their abil-
ity to transform xeno  biotics to reactive inter-
mediates (Massaro et al. 1994). Clara cells are 
considered multi  potent progenitor cells that 
regenerate airway epithelium after oxidant 
injury (Evans et al. 1976).
Xenobiotic Disruption of Lung 
Development
Chemical exposures that affect expression 
of important growth regulators can result in 
more severe effects or even lethality when the 
exposure occurs during susceptible periods of 
lung development. Table 1 summarizes these 
cellular and sub  cellular impacts, along with 
associated alterations in lung structure or func-
tion (and possible clinical implications) for 
individual chemicals discussed here. Potential 
windows of susceptibility for exposure can 
be inferred by comparing the information 
in Table 1 with the timeline of key develop-
mental periods in humans shown in Figure 2. 
Below we describe examples of xeno  biotics 
that alter lung development by disrupting 
essential processes such as branching morpho-
genesis, alveolarization, and cellular differen-
tiation and repair.
The congenital diaphragmatic hernia model 
and nitrofen. Congenital diaphragmatic hernia 
(CDH) is a serious condition in newborns, 
with an incidence of about 1 in 3,000 live 
births in the United States. Many die in utero; 
morbidity and mortality in the first days after 
birth are high (Hartman 2004). Although 
Table 1. Cellular, structural, and functional impacts on lung development of xenobiotics.
Chemical
Cellular and subcellular 




Down-regulates GATA-6, Wnt7, 
BMP4, FGF, and RALDH2; 
decreases RA synthesis; 
inhibits T3 receptor binding
Decreased branching; altered 




Brandsma et al. 1994; Leinwand et al. 2002; 
Major et al. 1998; Mendelsohn et al. 1994; 
Montedonico et al. 2008; Pongracz and 
Stockley 2006; Shu et al. 2002; Takayasu 
et al. 2007a; Wang et al. 2005
TCDD AhR, thyroid hormone Delayed lung development, 
decreased total lung space, 
increased septal area
Chronic bronchitis,a decreased 
functional capacity, chronic 
obstructive pulmonary 
disease (?)
Kransler et al. 2009; Rogan et al. 1988a; 
ten Tusscher et al. 2001
Nicotine Suppresses glycolysis and 
glycogenolysis, reduces 
synthesis of phosphorylase 
and phosphofructokinase, 
inhibits Na+/K+-ATPase
Slower septal formation, bleb 
formation, decreased number 
of alveoli, increased alveolar 
volume
Decreased functional capacity, 
emphysematous changes
Kordom 2004; Kordom et al. 2002; Maritz 1988, 




Inhibits bronchiolar cell 
differentiation and repair
Injury/loss of Clara cells Increased susceptibility to 
inhaled toxicants, alteration 
in surfactant
Fanucchi et al. 1997, 2004; Plopper et al. 1994; 
Smiley-Jewell et al. 1998, 2000
Ozone Depletes proteoglycan and 
Fgf2, alters Fgfr1, thinning 
basement membrane zone
Altered bronchiolar growth 
(longer/decreased diameter), 
fewer branches, alters 




emphysema (?), decrease 
in lung function growth,a 
asthma inductiona
Fanucchi et al. 2006; Galizia and Kinney 1999a; 
McConnell et al. 2002a; Plopper et al. 2007; 
Tager et al. 2005a 
Arsenic Increases ER-α expression, 
dysregulates matrix genes; 
β-catenin up-regulates EGFR, 
L-myc, and AFP
Altered branching and cell 
migration, decreased 




Guha Mazumder 2007a; Hays et al. 2008; Lantz 
et al. 2009; Petrick et al. 2009; Shen et al. 
2007; Smith et al. 2006a; Waalkes et al. 2003; 
Von Ehrenstein et al. 2005a
DEHP Binds to PPARγ, altering 
airway cell differentiation and 
surfactant protein production
Thickened primary septa, 
fewer/more dilated airspaces, 
increased type II pneumocytes
Bronchopulmonary dysplasia, 
altered lung mechanics, 
altered surfactant regulation, 
asthmaa
Bornehag et al. 2004a; Chang and Szabo 
2000; Magliozzi et al. 2003; Rosicarelli and 
Stefanini 2009; Yang et al. 2003; 
Abbreviations: AFP, α-fetoprotein; AhR, aryl hydro  carbon receptor; BMP4, bone morphogenetic protein 4; EGFR, epidermal growth factor receptor; ERα, estrogen receptor-α; L-myc, 
lung associated myc oncogene; PPARγ, peroxisome proliferator–activated receptor γ; RALDH2, retinal dehydrogenase 2; T3, triiodo  thyronine.
aIncludes evidence in humans. Impact of environmental chemicals on lung development
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CDH is associated with various genetic syn-
dromes, recent understanding of its etiology 
has been changing. Originally it was believed 
to be due to malformation in a portion of the 
diaphragm, which allowed compression of the 
developing lung by abdominal contents enter-
ing the chest cavity, resulting in the subsequent 
characteristic hypoplastic lung. More recently, 
evidence has supported a “dual hit” theory 
which postulates that the original injury occurs 
early in lung development before and not con-
nected to aberrant development of the dia-
phragm (Keijzer et al. 2000). According to this 
explanation, the already hypo  plastic developing 
lung is then further inhibited as a result of the 
mechanical compression on the ipsilateral side 
resulting from herniation of the intestines into 
the thoracic cavity.
Exposure to nitrofen (2,4-dichlorophenyl-
p-nitrophenyl ether), a banned pesticide, has 
been used as a model for CDH in rodents. 
Using this model, Leinwand et al. (2002) 
showed that the initial event in experimentally 
induced CDH is the development of hypo-
plastic lungs, which occurred early in devel-
opment before the closure of the diaphragm 
and herniation. Therefore, compression was 
not the initial cause of hypo  plasia. Hypoplasia 
has also been observed after nitrofen expo-
sure in animals without CDH (Cilley et al. 
1997). Lungs of nitrofen-exposed pups had 
30% fewer terminal bronchioles than did con-
trols, and they were developmentally immature 
(Leinwand et al. 2002). Similar observations in 
human infants with CDH include hypoplastic 
lungs, fewer alveoli, thickened alveolar walls, 
increased pulmonary interstitial tissue, and less 
airspace, as well as fewer bronchioles and vas-
cular branches (Gallot et al. 2005).
The list of effects induced by nitrofen on 
various signaling pathways related to branch-
ing morphogenesis and lung development has 
been rapidly increasing. Wnt (wingless signal-
ing proteins) growth factor signaling has been 
shown to have a role in regulation of prolifera-
tion, differentiation, and lineage specifica-
tion during embryonic development. In the 
lung, Wnt7 inactivation results in decreased 
branching and subsequent hypoplasia, as 
well as decreases in smooth muscle (Pongracz 
and Stockley 2006; Shu et al. 2002; Wang 
et al. 2005). Wnt signaling is an upstream 
regulator of bone morphogenetic protein 4 
(BMP4) and FGF, both important in lung 
development. Wnt7-null mice die at birth 
from severe lung hypoplasia. In mice treated 
with nitrofen, GATA-6 (an upstream acti-
vator of Wnt7b) Wnt7b, Wnt2, and BMP4, 
were down-regulated (Takayasu et al. 2007a). 
GATA-6, a zinc finger transcription protein, 
is an important regulator of distal epithelial 
cell differentiation, as well as proximal air-
way development (Yang et al. 2002). Prenatal 
RA partially mitigated the actions of prenatal 
nitrofen exposure in nitrofen-induced CDH 
rats (Montedonico et al. 2006, 2008).
Vitamin A–deficient diets have been 
linked to CDH in animal studies (Andersen 
1941), and a small human epidemiologic 
study found lower levels of retinol (the active 
metabolite of vitamin A) in newborns with 
CDH than in controls (Major et al. 1998). 
Knockout mice deficient in RA nuclear recep-
tors had an increased incidence of a spectrum 
of pulmonary agenesis, hypoplasia, and CDH 
(Mendelsohn et al. 1994). Nitrofen has been 
shown to disturb the RA signaling pathway at 
an early stage of lung develop  ment (Nakazawa 
et al. 2007a), and the incidence of CDH was 
dramatically reduced when RA was given 
along with nitrofen during pregnancy in rats 
(Babiuk et al. 2004). In rat lung explants, RA 
significantly increased the growth, number of 
lung buds, and lung area of nitrofen-induced 
hypoplastic lungs but had no effect on con-
trols (Montedonico et al. 2006). One possible 
mechanism of nitrofen’s action on retinol may 
be to interfere with its cellular uptake during 
lung morphogenesis (Nakazawa et al. 2007b). 
Previous studies have suggested activity by 
inhibiting retinal dehydrogenase 2 (RALDH2), 
a key enzyme for generation of RA from retinal. 
Four chemicals shown to be able to precipi  tate 
development of CDH in animal models (nitro-
fen, bisdiamine, 4-diphenyl carboxylic acid, 
and SB210661) all have been found to inhibit 
RALDH2 (Mey et al. 2003).
One of the key processes in later ges-
tation is the differentiation of a portion of 
alveolar type II cells to alveolar type I cells. 
That process was impaired in the nitrofen-
induced CDH lung (Takayasu et al. 2007b). 
Although it appears that the immediate cause 
of decreased differentiation into type I cells 
was mechanical compression, this can be 
considered a secondary effect of the chemical 
exposure and was not observed in the absence 
of nitrofen exposure.
Thyroid-disrupting chemicals and branch-
ing morphogenesis. Thyroid hormone is 
important for normal lung development (Van 
Tuyl et al. 2004). For example, alveolar septa-
tion, a largely post  natal structural manifes-
tation, was impaired in hypothyroid mouse 
pups (Van Tuyl et al. 2004). The ratio of 
surfactant protein mRNA expression to that 
of corresponding proteins was influenced by 
both prenatal and postnatal thyroid hormone 
deficiency. A reduced ratio is indicative of an 
immature lung.
Nitrofen is a diphenyl ether and, like 
related chemicals, has anti  thyroid activity 
(Brandsma et al. 1994), inhibiting triiodo-
thyronine (T3) receptor binding. Little 
research has been published on the effect of 
other environ  mental chemicals with anti-
thyroid activity on lung development. Dioxins, 
polychlorinated biphenyls (PCBs), and 
polybrominated diphenyl ethers are structurally 
simi  lar to nitrofen and have known anti  thyroid 
activity. A significant increase in the incidence 
of “bronchitis” was noted in a Taiwanese 
cohort of children exposed to PCBs pre  natally 
(Rogan et al. 1988), which may involve PCB 
impairment of immune function and/or lung 
development. In an epidemiologic study in 
the Netherlands, ten Tusscher et al. (2001) 
found prenatal/lactational exposure to dioxins 
to be related to a significant reduction in lung 
function in 41 healthy children between 7 and 
12 years of age. Gestational exposure in rats to 
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 
resulted in up-regulation of aryl hydro  carbon 
receptor (AhR) signaling in the developing 
lung and delayed lung development as evi-
denced by decreased total lung airspace and 
increased septal area (Kransler et al. 2009). 
These hypoplastic changes in lung morphology 
were associated with functional differences in 
respiratory mechanics. The study suggests that 
AhR activation adversely affects lung develop-
ment. Up-regulation of AhR activity results in 
decreases in thyroid hormone due to increased 
metabolism. Thus, decreased thyroid hormone 
may play a role in these findings.
We identified no other studies that exam-
ined developmental exposure to thyroid- 
disrupting environmental chemicals and lung 
function. Lung function studies are a sensi-
tive, minimally invasive method of meas  uring 
impact on lung development. Measurements 
of lung function in experimental animal pups 
would provide additional useful information 
on adverse lung impacts in developmental tox-
icity studies. In addition, more epidemiologic 
studies evaluating lung function in people 
exposed pre  natally and post  natally to thyroid-
hormone–disrupting chemicals are needed.
Examples of disruption of branching mor-
phogenesis by environmental chemicals in 
other organ systems. Branching morpho  genesis 
is an essential developmental process for many 
organs that use common signaling pathways. 
One of the organs that exhibit branching 
morphogenesis is the salivary gland. TCDD 
exposure of cultured murine sub  mandibular 
glands reduced epidermal growth factor sig-
naling. This aryl hydrocarbon–associated 
effect inhibited branching morphogenesis and 
resulted in smaller glands with enlarged buds 
(Kiukkonen et al. 2006). This effect was seen 
in cells cultured at gestational day (GD) 13 
but not later in development, indicating a spe-
cific window of susceptibility. Development 
of the prostate in the mouse is also inhibited 
by exposure to TCDD during pregnancy and 
lactation. Exposure on GD13 to a single dose 
resulted in reduced organ weight related to an 
inhibition of development of prostatic epi-
thelial buds (Ko et al. 2002). Inhibition of 
prostatic bud development by TCDD is not 
androgen dependent (Lin et al. 2004).Miller and Marty
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TCDD exposure during a critical window 
of gestation produced disruption of branching 
morphogenesis in the rat mammary gland, 
resulting in smaller glands, limited branch-
ing, decreased numbers of terminal end 
buds, and a lack of substantial alveolar lob-
ule development independent of hormonal 
effects (Fenton et al. 2002; Vorderstrasse et al. 
2004). This effect was dependent on the time 
of exposure: It was observed after exposure on 
GD15 but not GD20, and persisted at least 
until postnatal day 45 (post  pubertal) (Fenton 
et al. 2002). 
Retinoids are involved in embryonic kid-
ney patterning and development, including 
branching morphogenesis, and are impor-
tant in kidney development. The Ret receptor 
modu  lates ureteric bud branching morpho-
genesis (Gilbert 2002). Nitrofen expo-
sure resulted in hypo  plastic kidneys in rats 
(Montedonico et al. 2007).
Exposure of rats in utero to the herbi-
cide atrazine has been associated with altered 
branching morphogenesis in the mam-
mary gland, although little detail is known 
of the exact mechanism of action (Rayner 
et al. 2005). Similarly, the mammary glands 
of offspring exposed during GD17–GD19 
displayed delay in development of mature 
gland structures and less epithelial branching. 
Importantly, the offspring of atrazine-treated 
dams were unable to provide adequate nutri-
tional support for the F2 offspring, resulting 
in decreased pup weight gain.
Clearly, the impact of exposure during 
critical windows of development to environ-
mental chemicals that disrupt branching mor-
phogenesis has been demonstrated in various 
organ systems dependent on this process. 
Chemicals that inhibit this process in one 
organ should be investigated for similar effects 
on lung development.
Nicotine and alveolarization. The glyco-
lytic pathway is very active during the alveo-
lar phase of lung development and provides 
energy and precursors to the lung. Maternal 
exposure to nicotine in the rat resulted in 
sustained or permanent suppression of gly-
colysis and glycogenolysis in the lung tis-
sue of the pup (Maritz 1986, 1988), due 
to reduced synthesis of phosphorylase and 
phospho  fructo  kinase (the rate-limiting step 
in glycolysis) in nicotine-exposed animals 
(Kordom 2004; Kordom et al. 2002; Maritz 
2004). As a result of inhibited glycolysis, Na+/
K+-ATPase is inhibited, which may result in 
swelling and bleb formation of alveolar type I 
cells (reviewed by Maritz 2008). 
In rats, maternal dosing with nicotine dur-
ing pregnancy and lactation, at doses that did 
not alter fetal growth, resulted in a significant 
decrease in number of alveoli and increase in 
the alveolar volume at maturity in nicotine-ex-
posed pups relative to controls (Maritz 2002; 
Maritz and Windvogel 2003). The increase 
in alveolar volume in nicotine-exposed pups 
was attributed to slower alveolar septal for-
mation, flattening of the alveoli as they aged, 
and disappearance of alveolar walls leading 
to larger alveoli. The histo  pathology of nico-
tine-exposed animals resembled early emphy-
sema (Maritz and Windvogel 2003). Routine 
pathologic examination of these lungs would 
likely fail to demonstrate these relatively subtle 
changes. Such irreversible changes could result 
in dysfunction (emphysema) in later life.
Xenobiotics and cell differentiation and 
repair. In the rabbit, Clara cells actively dif-
ferentiate postnatally, reaching maturity at 
4 weeks. Despite lower levels of CYP450 activ-
ity in immature neo  natal Clara cells, these cells 
were more susceptible to injury at lower doses 
of 4-ipo  meanol than adult cells (Plopper et al. 
1994). Smiley-Jewell et al. (2000) treated rab-
bits with ipo  meanol during three postnatal 
time periods that represent early, intermediate, 
and final stages of Clara cell maturation. In 
rabbits treated with a single dose of 4-ipo-
meanol during early or middle periods of dif-
ferentiation (up to 9 days of age), bronchiolar 
cell differentiation and repair were inhibited. 
The period of greatest susceptibility was during 
mid-differentiation at 7 days of age. On exam-
ination at 6 weeks, rabbits treated at day 7 
had more squamous cells, fewer ciliated cells, 
reduced expression of Clara cell markers, and 
undifferentiated cuboidal cell ultra  structure 
compared with those treated at adulthood. In 
those treated at later stages of development 
(21 days), repair was completed during this 
time period, and the bronchiolar epithelium 
was indistinguishable from controls at 6 weeks 
(Smiley-Jewell et al. 2000). Thus, the extent 
of repair was related to the stage of cellular 
differentiation at the time of injury but inde-
pendent of the degree of injury (Smiley-Jewell 
et al. 1998, 2000). Exposure during the criti-
cal window of early development dispropor-
tionately inhibited differentiation and repair of 
bronchiolar Clara cells, resulting in persistent, 
possibly permanent effects.
Similarly, naphthalene, another bio-
activated Clara cell toxicant, has been found 
to induce injury at much lower doses in 
immature mice (Fanucchi et al. 1997). 1-Ni-
tronaphthalene, an atmospherically formed 
nitro  aromatic, more severely affects immature 
than mature Clara cells in both mice and rats 
(Fanucchi et al. 2004).
These findings suggest that Clara cell 
injury by bio  activated chemicals in the devel-
oping animal is not necessarily predicted by 
the level of CYP450 enzyme activity. There is 
no reason to believe this is restricted to mice, 
rats, and rabbits. Susceptibility of the neonate 
to injury cannot be predicted by the findings 
in adults. Early-life injury may be a precursor 
to dysfunction later in life.
Widespread Environmental 
Chemicals That Disrupt 
Lung Development
Ozone. Lung development occurs not only 
prenatally but through childhood, and lung 
function grows at least through adolescence. 
Therefore, exposure to environmental toxi-
cants may affect underlying structural and 
functional aspects of the lung during a wide 
window. This may increase susceptibility to 
asthma as well as other diseases.
An elegant series of studies conducted at 
University of California–Davis evaluated the 
impact of ozone (O3) and allergens on lung 
development in rhesus monkeys. These studies 
integrated early-life exposures through multiple 
windows of susceptibility to observe functional 
and structural changes relevant to human lung 
development and lung disease. Tran et al. 
(2004a) described conducting airway growth 
studies in monkeys, with airways doubling 
in length and increasing by 33% in diame-
ter between 1 and 6 months of age. Postnatal 
exposure to O3, alone or combined with 
house dust mite antigen (HDMA), resulted 
in changes in bronchiolar growth patterns, 
inhibiting growth in diameter and promoting 
growth in length (Figure 3), as well as reduc-
ing the number of conducting airway branches 
(by as many as six generations) (Fanucchi et al. 
2006; Plopper et al. 2007). These changes 
appeared to be permanent because they per-
sisted after 6 months of recovery.
In monkeys, the smooth muscle bundles 
grow along with the conducting airways and 
have characteristic alterations depending on 
location and age (Tran et al. 2004a). Muscle 
bundles progress with age from a primarily 
perpendicular orientation relative to the long 
axis of the airway in early development to an 
orientation with a large percentage of bun-
dles > 30° from perpendicular. This process 
is disrupted by exposure to HDMA or O3 in 
rhesus monkeys (Fanucchi et al. 2006; Tran 
et al. 2004b). The smooth muscle bundles 
were thickened, and their orientation rela-
tive to the airway in the respiratory bronchi-
oles was altered by exposure to O3 such that 
a much higher percentage of the bundles were 
< 15° perpendicular to the long axis of the 
bronchiole, an alteration that may increase air-
way hyper  reactivity (Plopper et al. 2007). The 
changes noted above from O3 exposure were 
not associated with changes in lung volume 
or function as measured by routine testing. 
The effect of the structural changes found after 
exposure to HDMA and O3 is consistent with 
alterations in airflow and resistance found in 
asthmatics (James and Carroll 2000; Plopper 
et al. 2007; Tran et al. 2004b). Epidemiologic 
evidence suggests that exposure to O3 is asso-
ciated with asthma induction in children 
(McConnell et al. 2002) and reduced lung Impact of environmental chemicals on lung development
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function growth (Galizia and Kinney 1999; 
Tager et al. 2005).
In infant rhesus monkeys, chronic cyclic 
O3 exposure (0.5 ppm, 8 hr/day, for 5 days, 
followed by 9 days of filtered air, for 11 cycles) 
induced biochemical and functional alterations 
(depleted proteo  glycan and Fgf2, altered Fgfr1) 
and thinning of the basement membrane zone 
(Fanucchi et al. 2006). This tissue binds and 
releases growth factors, is involved in cell–cell 
communication, and functions as a barrier. The 
alteration of Fgf2 signaling, important for regu-
lating processes in the developing lung, may 
be associated with the reported O3-induced 
abnormal develop  ment of alveolar and bron-
chiolar regions in animal models.
Arsenic. Arsenic is a known human car-
cinogen, causing lung cancer after inhalation 
and oral exposure. Long-term arsenic expo-
sure through drinking water has also been 
associated with chronic non  malignant respi-
ratory disease and decreased lung function 
(Guha Mazumder 2007). In men exposed 
in West Bengal, India, chronic ingestion of 
arsenic was a stronger determinant of lung 
function than was smoking, and decreases in 
FEV1, FVC, and FEF25–75 indicated restric-
tive patho  physiology involving the small air-
ways (von Ehrenstein et al. 2005).
Several studies have demonstrated trans-
placental carcinogenesis in animal models. 
Waalkes et al. (2003) reported that in utero 
arsenic exposure in C3H mice resulted in 
tumori  genesis in a number of organs, including 
the lung. These investigators reported increased 
lung tumors in adult females, but not in males. 
In humans, exposure to arsenic via drinking 
water in utero and postnatally was associated 
with much larger increases in lung cancer and 
bronchiectasis in a population in Chile than 
were later-life exposures (Smith et al. 2006). 
Thus, arsenic exposure early in life is associ-
ated with both chronic obstructive lung disease 
and lung cancer, and data from animal models 
indicate that this may result from aberrant sig-
naling during lung development.
Gestational arsenic exposure increased 
expression of the estrogen receptor-α gene 
(ER-α) and genes related to estrogen signaling 
in the female fetal mouse lung after environ-
mentally relevant exposures via drinking water 
(Shen et al. 2007). This correlated to intense 
over  expression of ER-α protein in lung 
tumors in adult females exposed gestationally. 
These authors also observed activation of a 
number of genes associated with lung cancer 
development, including EGFR (epidermal 
growth factor receptor), AFP (α-fetoprotein), 
and L-myc (lung associated myc oncogene) 
after gestational exposure. 
The extracellular matrix in the lung per-
forms various functions, including providing 
structural support for cells, regulating inter-
cellular communication, and storing growth 
factors locally. Extracellular matrix fibers 
include collagen (structural support) and elas-
tin (elasticity). Matrix genes were dysregu-
lated by chronic arsenic exposure in adult mice 
(10 or 50 ppb), including down-regulation of 
the gene for collagen, elastin, and fibronectin 
and up-regulation of the matrix-degrading 
enzyme MMP-9 (Hays et al. 2008; Lantz and 
Hays 2006). In vitro exposure of human epi-
thelial cells to arsenic also caused up-regula-
tion of MMP-9 and restricted wound repair 
(Olsen et al. 2008). Collagen-knockout mice 
have increased smooth muscle around the air-
ways (Dekkers et al. 2007; Parameswaran et al. 
2006). Similarly, in utero and early post    natal 
exposure of mice to environmentally rele  vant 
levels of arsenic resulted in decreased total col-
lagen in the airway adventitia and increased 
smooth muscle surrounding the airway 
at 28 days of age (Lantz et al. 2009). These 
mice exhibited airway hyper  responsive  ness as 
increased broncho  constriction in response to 
methacholine challenge. The structural altera-
tions were not present in mice exposed to arse-
nic as adults. Because these irreversible findings 
were identified by immuno  histo  chemistry and 
methacholine challenge, they would not likely 
be identified by standard toxicology studies.
Arsenic can disrupt the highly complex 
signaling between embryonic lung tissues of 
mesen  chymal and endodermal origin and can 
permanently alter lung structure and function 
when exposure occurs at key develop  mental 
windows. Petrick et al. (2009) exposed preg-
nant rats to 500 ppb arsenic via drinking water 
starting at GD1 and evaluated gene expression 
in fetal lung on GD18. Lung weights were 
lower in arsenic-exposed pups than in con-
trols. Arsenic exposure altered expression of 
key genes in pathways involved in lung devel-
opment, including the β-catenin pathway, 
which is required for proper cell migration 
during branching morphogenesis. Deletion of 
the β-catenin gene in epithelial cells resulted in 
a lack of peripheral lung structures (Mucenski 
et al. 2003). Thus, altered signaling caused by 
arsenic exposure results in poor airway struc-
ture. Malformed airways are characteristic of 
bronchiectasis, which is observed in humans 
exposed to arsenic via drinking water.
Figure 3. Diagrammatic comparison of differences in the size of one generation of distal bronchiole in the 
left cranial lobe of infant rhesus monkeys (180 days of age) following 11 cycles of exposure to filtered air 
(FA), HDMA, O3, or both HDMA and O3. The airway measured is the bronchiole proximal to the terminal 
bronchiole in the axial airway path of the caudal segment of the left cranial lobe of each animal. Relative 
scaling for length (l) and diameter (d) is based on setting the value for 30-day-old animals (when exposure 
began) equal to “l.” Reprinted from Plopper et al. (Plopper CG, Smiley-Jewell SM, Miller LA, Fanucchi MV, 
Evans MJ, Buckpitt AR, et al. 2007. Asthma/allergic airways disease: does postnatal exposure to environ-
mental toxicants promote airway pathobiology? Toxicol Pathol 35:97–110), Toxicologic Pathology Vol. 35(1); 
copyright 2007; reprinted by permission of SAGE Publications. Miller and Marty
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Di(2-ethylhexyl) phthalate. The phtha-
late ester plasticizers interact with the nuclear 
hormone receptor superfamily peroxisome 
proliferator–activated receptor (PPAR) and 
are thereby capable of modulating gene tran-
scription in a number of tissues.
There are significant levels of PPARγ in 
human lung (Chang and Szabo 2000), and 
di(2-ethylhexyl) phthalate (DEHP) metabo-
lites can bind to these receptors. Through the 
use of transgenic mice, epithelial cell PPARγ 
has been shown to be directly involved in lung 
maturation, probably through altering airway 
cell differentiation and resultant phenotype 
(Simon et al. 2006). Lungs of mice whose con-
ducting airways are deficient in PPARγ develop 
abnormally and have enlarged airspaces and 
altered lung mechanics, possibly due to altered 
epithelial–mesenchymal interactions during 
development.
Rats exposed during the last week of preg-
nancy and first 2 days postnatally via oral 
administration of 1,000 mg/kg-day DEHP 
to the dams had abnormal lung histology 
(Magliozzi et al. 2003). Focal thickening of 
primary septa was evident, and there were 
more dilated air spaces in the parenchyma in 
DEHP-treated pups, resulting in a decrease in 
gas exchange surface. Type II pneumo  cytes, 
which are a major source of surfactant, were 
enlarged and more numerous in treated pups 
than in control pups. These authors noted 
that lung parenchymal changes were simi  lar 
to that seen in children with chronic lung 
disease and in animal models of broncho-
pulmonary dysplasia. The histopathology sug-
gests impaired alveolar maturation and not 
tissue degeneration. Magliozzi et al. (2003) 
also noted that type II pneumo  cytes were 
more numerous and larger in the DEHP-
treated pups and that the peroxi  somes in the 
alveolar type II pneumo  cytes of treated pups 
appeared unaffected; thus, they suggested that 
DEHP action in the fetal lung is not depen-
dent on interaction with the PPARα. Rather, 
the effect might be due to interaction with 
PPARγ to alter surfactant production, secre-
tion, or reabsorption by type II cells. PPARγ 
ligands have been shown to down-regulate 
surfactant protein B expression in alveolar 
type II cells (Yang et al. 2003). Rosicarelli and 
Stefanini (2009) reported that DEHP may 
affect alveolar develop  ment by disrupting the 
timing of epithelial and mesen  chymal cell 
proliferation; they found that DEHP treat-
ment of the dams was associated with both 
an impaired secretion pattern and altered 
proliferation rate of septal myo  fibro  blasts. In 
a nested case–control study of 198 children 
with allergic symptoms and 202 controls, 
Bornehag et al. (2004) identified a statistically 
significant association between DEHP lev-
els in household dust and doctor-diagnosed 
asthma. The inter  actions of the ubiquitous 
phthalate ester plasticizers such as DEHP 
with PPARγ during lung development need 
further study. 
Conclusion
The lung is susceptible to many influences dur-
ing early development, including endogenous 
hormones, pharmaceuticals, and environ-
mental chemicals. Chemical exposure during 
develop  mental windows may produce lifelong 
structural and functional alterations, and some 
may become apparent only later in life (e.g., 
as lung function naturally declines with age). 
Susceptible maturational events occur through-
out pre  natal development, post  natally, and 
through adolescence. Evidence is accumulating 
that clinically signifi  cant disruption of lung 
development may be caused by some xeno-
biotics at environmentally relevant doses (e.g., 
arsenic, O3). Nonetheless, there is a paucity 
of literature evaluating the impact of early-life 
exposure to environmental chemicals on lung 
structure and function.
Many fundamental biologic processes 
(e.g., branching morphogenesis) and associ-
ated signaling events involved in development 
of multiple organs are highly conserved. A 
variety of transcription factors and morpho-
regulatory molecules essential to these processes 
are susceptible to interference during critical 
develop  mental stages. Examples presented in 
this review highlight the potential of a chemi-
cal to affect develop  ment in multiple organs 
that use the same fundamental patterning and 
developmental building blocks. Although local 
tissue differences may alter the impact of sig-
naling disruption, a chemical that is identified 
as having the potential to disrupt fundamental 
processes in one organ (e.g., dioxin disrupt-
ing branching morpho  genesis in the prostate) 
should be evaluated appropriately for similar 
impacts in the lung. In addition, chemicals 
that are structurally similar (e.g., PCBs) to 
those known to affect the developing lung (e.g., 
nitrofen) should be evaluated with appropriate 
studies for their impact on lung development.
Studies to determine the potential toxicity 
of xenobiotics resulting from early-life expo-
sures should incorporate knowledge of early 
signaling events into experimental protocols. 
Evidence from animal studies indicates that 
many lung alterations induced by environ-
mental chemicals require functional and/or 
highly specific studies targeted at identifying 
alterations of structure or function. Many of 
the functionally significant impacts of early-
life exposures on lung development we dis-
cussed here would not have been identified 
with standard toxicologic study protocols.
Risk assessment practice should use data 
on disruption of basic developmental processes 
to inform the size of applied uncertainty fac-
tors. When there is evidence that a chemical 
can disrupt relevant signaling pathways but 
develop  mental toxicity data are inadequate, 
uncertainty related to this data gap should 
be reflected in the assessment. For example, 
the risk assessor could increase the size of the 
intra  species uncertainty factor used in non-
cancer risk assessment to account for increased 
sensitivity of early life stages.
The U.S. Environmental Protection 
Agency (EPA) Strategic Plan for Evaluating 
the Toxicity of Chemicals (U.S. EPA 2009) 
and the National Academy of Sciences report 
Toxicity Testing in the 21st Century (National 
Research Council 2007) envision a transfor-
mation in the approach to toxicity testing 
that focuses on “toxicity pathways.” Toxicity 
pathways are “cellular response pathways that, 
when sufficiently perturbed in an intact ani-
mal, are expected to result in adverse health 
effects” (National Research Council 2007). 
These cellular pathways include key signal-
ing pathways in development. The U.S. EPA 
(2009) noted that “an inventory of toxicity 
pathways and their involvement in a variety 
of toxicological responses needs to be created.” 
We suggest that the key signaling pathways 
in branching morphogenesis (e.g., a highly 
conserved funda  mental develop  mental pro-
cess that uses similar signaling pathways across 
multiple organs) represent important toxic-
ity pathways. Evidence that a chemical inter-
feres with an important signaling event should 
inform decisions on relevant end points for 
studies of develop  mental toxicity and help 
identify chemical groupings for which a 
cumulative evaluation may be appropriate, 
because they affect the same toxicity path-
way. Ultimately, knowledge of the impacts of 
xeno  biotics on lung develop  ment can be used 
to develop policies promoting true primary 
prevention of chronic obstructive pulmonary 
disease, asthma, and other lung diseases.
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